COMMUNIQUÉS West-GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
26/02/2025
LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment
26/02/2025
The study demonstrated that lanifibranor improved Portal Hypertension (PH) in mouse models of fibrotic PH and prehepatic non-fibrotic PH Lanifibranor was observed to decrease portal pressure by improving Liver [...]
Inventiva annonce la publication dans Biomedicine & Pharmacotherapy des résultats d'une étude préclinique montrant une amélioration de l'hypertension portale avec le traitement par lanifibranor
26/02/2025
L'étude a démontré que lanifibranor améliorait l'hypertension portale (HTP) dans des modèles murins d'HTP fibrotique et d'HTP non fibrotique préhépatique Il a été observé que lanifibranor réduit la pression portale en [...]
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
26/02/2025
Fourth quarter revenue growth of 28% to $24.7 million 2024 revenue growth of 28% to $90.0 million 68% improvement in adjusted EBITDA in fourth quarter Conference call with Q&A today at 4:30 PM EST / 22:30 CET IRVINE [...]
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025
26/02/2025
NASHUA, N.H. and CHICAGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer detection solutions, and Koios Medical , a leader in AI-driven ultrasound [...]
Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment
26/02/2025
SARASOTA, FL, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
26/02/2025
Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond LOS ANGELES, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Renovaro [...]
AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
26/02/2025
OCALA, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it received notice from the NYSE American (the “American”) that the American has [...]
RAMSAY SANTE :Half-year Financial Report as at end of December 2024 disposal
26/02/2025
Paris, February 26, 2025 RAMSAY SANTE Half-year Financial Report as at end of December 2024 disposal This document is available on RAMSAY SANTE Internet site : http://www.ramsaysante.fr About Ramsay Santé : Ramsay Santé [...]
RAMSAY SANTE : Mise à disposition du rapport financier semestriel au 31 décembre 2024
26/02/2025
Paris, le 26 février 2025 RAMSAY SANTE Mise à disposition du rapport financier semestriel au 31 décembre 2024 Ce document est disponible sur le site internet de RAMSAY SANTE : http://www.ramsaysante.fr A propos de [...]
RAMSAY SANTE : Half-year results at the end of December 2024
26/02/2025
PRESS RELEASE Paris, 26 th February 2025 Half-year results at the end of December 2024 Confirmed fundamentals Strengthening access to healthcare for all as a mission-driven company, Ramsay Santé, thanks to its employees [...]
RAMSAY SANTE : Résultats semestriels à fin décembre 2024
26/02/2025
COMMUNIQUÉ DE PRESSE Paris, le 26 février 2025 Résultats semestriels à fin décembre 2024 Confirmation des fondamentaux Renforçant l'accès aux soins pour tous en tant qu'entreprise à mission, Ramsay Santé, grâce à ses [...]
Acorn Health Expands Autism Diagnostic Services in Michigan
26/02/2025
CORAL GABLES, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Acorn Health, a leading provider of applied behavioral analysis therapy, now offers autism spectrum disorder (ASD) testing and diagnostic services across Northern [...]
Shuttle Pharma Provides Corporate Update and Reports 2024 Results
26/02/2025
GAITHERSBURG, Md., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused [...]
H.H.C. Group Achieves ISO Certification, Highlighting Commitment to Excellence in Healthcare Cost Containment
26/02/2025
ROCKVILLE, Md., Feb. 26, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C), the leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]
Derm-Biome’s DB-007-5 is highly effective at treating atopic dermatitis and reducing itch in preclinical study, outperforming the current leading topical AD drug
26/02/2025
VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy ageing, is pleased to announce that its [...]
Toronto to Host EmpowerHER Women’s Health Summit on March 1, 2025: Uniting Top Experts for Transformative Change
26/02/2025
Uniting renowned thought leaders to drive innovative solutions for women’s wellness TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The 1st Annual EmpowerHER Women’s Health Summit , hosted by Bridge Medical Communications, [...]
Biongevity Celebrates Success of World’s First Longevity Fitness Challenge in UAE & Announces Longevity Health Plans
26/02/2025
UAE’s First Longevity Fitness Challenge Proves Science-Backed Health Optimization Work CALGARY, Alberta, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Biongevity, a subsidiary of BioAro and a global leader in AI-driven health [...]
Zevra to Report 2024 Fourth Quarter and Full Year Financial Results
26/02/2025
Company will host conference call on Tuesday, Mar. 11, 2025, at 4:30 p.m. ET CELEBRATION, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage [...]

Pages